Article
Influence of ABCB-1, ERCC-1 and ERCC-2 gene polymorphisms on response to capecitabine and oxaliplatin (CAPOX) treatment in colorectal cancer (CRC) patients of South India.
Journal of clinical pharmacy and therapeutics - 1 Aug 2020
Varma Ashok, Mathaiyan Jayanthi, Shewade Deepak, Dubashi Biswajit, Sunitha Kodidela
Abstract excerpt
WHAT IS KNOWN AND OBJECTIVE: High interindividual response variability was reported with capecitabine and oxaliplatin (CAPOX) regimen in colorectal cancer (CRC). The single nucleotide polymorphisms (SNPs) of the genes related to drug efflux transport (ABCB1) and DNA repair (ERCC) could result in altered tumour response. Hence, this study was designed to assess the influence of ABCB1, ERCC-1 and ERCC-2 gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
